14Jun 2023
Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression

Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression

During solid tumour progression, the tumour microenvironment (TME) evolves into a highly immunosuppressive milieu. Key players in the immunosuppressive environment are myeloid regulatory cells, including myeloid-derived suppressor cells (MDSCs) and tumour-associated macrophages (TAMs), which are recruited and activated via tumour-secreted cytokines such as colony-stimulating factor 1 (CSF-1). Therefore, the depletion of tumour-secreted cytokines is a leading anticancer strategy. This study found that CSF-1 secretion by melanoma cells is decreased following treatment with Cannabis extracts. It also shows a novel mechanism for CBG in modulating the TME and enhancing immune checkpoint blockade therapy, underlining its promising therapeutic potential for treating a variety of tumours with elevated CSF-1 expression.

  • #oncology

Like

Save

Share